(N-tetrahydrofurfuryl)noroxymorphone

Subscribe to Selected New Research on (N-tetrahydrofurfuryl)noroxymorphone

1 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: RN given refers to (5alpha,17(R))-isomer

Also Known As:

(N-tetrahydrofurfuryl)noroxymorphone hydrochloride, (5 alpha,17(R))-isomer; (N-tetrahydrofurfuryl)noroxymorphone hydrochloride, (5 alpha,17(S))-isomer; (N-tetrahydrofurfuryl)noroxymorphone, (5 alpha,17(S))-isomer; MR 2096; MR 2097; MR-2096; MR-2097

Bio-Agent Context: Research Results

Heterocyclic Compounds: 23

Alkaloids: 637

Opiate Alkaloids: 10

Morphinans: 5

(N-tetrahydrofurfuryl)noroxymorphone: 1

Bridged-Ring Heterocyclic Compounds

Morphinans: 5

(N-tetrahydrofurfuryl)noroxymorphone: 1

Heterocyclic Compounds with 4 or More Rings

Morphinans: 5

(N-tetrahydrofurfuryl)noroxymorphone: 1

Polycyclic Compounds: 58

Aromatic Polycyclic Hydrocarbons: 581

Phenanthrenes: 6

Morphinans: 5

(N-tetrahydrofurfuryl)noroxymorphone: 1

Related Diseases

Hyperalgesia

04/01/1985 - "The absence of hyperalgesia in the tail flick test following the central administration of Mr 2097 might arise from a rapid fall in concentration at relevant receptor sites and/or absence of a significant effect on the spinal reflex"
04/01/1985 - "Subcutaneous administrations of Mr 2096, the agonist diastereoisomer and Mr 2097, the antagonist diastereoisomer respectively produced analgesia and hyperalgesia in these tests, confirming the involvement of stereoselective opioid receptors in the regulation of thermonociception"
Order ALL the reference details at left...

Related Drugs and Biologics

1.	(N-tetrahydrofurfuryl)noroxymorphone
2.	Opioid Receptors (Opioid Receptor)

Related Therapies and Procedures

1.	Analgesia

Best Treatments:
Research Summary Report
on Hyperalgesia

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 214 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>